Alendronate for the treatment of osteoporosis in men.

Alendronate for the treatment of osteoporosis in men. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Alendronate for the treatment of osteoporosis in men. Abstract Text:

W P Olszynski,K S Davison,W P Olszynski,K S Davison,

BACKGROUND: Men have higher rates of osteoporosis and suffer fragility fractures more often than previously believed. Fracture-related morbidity and mortality in men is substantially higher than in women. OBJECTIVE: To investigate alendronate for treating osteoporosis in men. METHODS: Search limited to 'men' and 'English'; keywords were 'osteoporosis' or 'bone density' or 'fracture' and 'alendronate'. RESULTS/CONCLUSIONS: Alendronate is an amino-bisphosphonate with proved efficacy for increasing bone mineral density in men with idiopathic or secondary osteoporosis and has demonstrated an ability to prevent vertebral fractures in men with low bone mass. There are trends for alendronate to decrease the risk of non-vertebral fracture, but larger trials are needed to conclusively establish this benefit. Alendronate is a well-tolerated and comparatively safe drug with an attractive once-a-week dosing regimen.

Alendronate for the treatment of osteoporosis in men. Publishing Authors By Initials

WP Olszynski,KS Davison,WP Olszynski,KS Davison,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Alendronate for the treatment of osteoporosis in men. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Expert opinion on pharmacotherapy

VOLUME: 9

Page Numbers: 491-8

Journal Abbreviation:

ISSN: 1744-7666

DAY: 28

MONTH: Feb

YEAR: 2008

Alendronate for the treatment of osteoporosis in men. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100897346

Alendronate for the treatment of osteoporosis in men. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Alendronate for the treatment of osteoporosis in men. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Alendronate for the treatment of osteoporosis in men.

AFFILIATION: University of Saskatchewan, Saskatoon, SK, Canada. olszynski@webster.sk.ca

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Expert Opin Pharmacother

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Alendronate for the treatment of osteoporosis in men Related Publications

• A face lift approach for sentinel node biopsy in head and neck melanoma patients.
• A longitudinal assessment of the links between physical activity and self-esteem in early adolescent non-Hispanic females.
• Actual use and perceived usefulness of a web-based, decision support program for men with prostate cancer.
• Advanced pubertal status at age 11 and lower physical activity in adolescent girls.
• Alendronate for the treatment of osteoporosis in men.
• Cerebral allergy.
• Children's history of speech-language difficulties: genetic influences and associations with reading-related measures.
• Congenital hypoplasia of the carpal scaphoid bone.
• Essentials of plastic surgery.
• Expanding roles of Aboriginal health workers in the primary care setting: seeking recognition.
• Haemolytic effects of myanesin.
• Health versus weight as motivations for physical activity among adolescent girls have different antecedents and consequences: 889: june 1 4:15 PM - 4:30 PM.
• How Long to Prosecute Child Sexual Abuse for a Community Using a Children's Advocacy Center and Two Comparison Communities?
• Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers.
• Inhibition of brain monoamine oxidase.
• Kala-azar; three cases developing in veterans.
• Neurochemistry of Alzheimer's disease: an update.
• Opioid use in renal failure #161.
• Pentamethonium iodide in anaesthesia.
• Proof Of Concept: Success Factors In Establishing A Private Sports Medicine Practice In The UK: 2190: Board #103 June 1 8:00 AM - 9:30 AM.
• Reconstructive application of the endotine suspension devices.
• Relaxation therapy lowers blood pressure more effectively in hypertensives with raised plasma norepinephrine and blunts pressor response to anger.
• School contact tracing for tuberculosis using two-step Mantoux testing.
• Size and density distribution of sulfide-producing microniches in lake sediments.
• Telomeres and telomerase in leukaemia and lymphoma.
• The Effects of Acute Exercise on Pulse Wave Velocity and Postprandial Lipaemia in men: 1766: Board #54 May 31 8:00 AM 9:30 AM.
• The discovery of ether.
• The increased hypoprothrombinemic effect of a small dose of dicumarol in congestive heart failure.
• The prevalence and management of chronic pain in end-stage renal disease.
• Undergraduate and postgraduate pediatric education in medical schools.